Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. News
  7. Summary
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Seegene, Inc.'s Equity Buyback announced on March 9, 2021, has expired.

09/28/2021 EST

The company expired its plan on September 28, 2021.


ę S&P Capital IQ 2021
All news about SEEGENE, INC.
11/30Seegene's High Multiplex Pcr Assay Capable of Detecting New Omicron Variant
CI
11/30Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant
AQ
11/23Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum
AQ
11/15Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
AQ
11/15Seegene Opens New Subsidiary in Bogot?, Colombia, to Advance Regional COVID-19 Testing
CI
11/15Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
10/27SEEGENE INC. ANNOUNCES LAUNCH OF STA : All-in-One System Fulfills Critical Need for Fully ..
CI
10/27LAUNCH OF SEEGENE'S STARLET-AIOS : All-in-One System Fulfills Critical Need for Fully Auto..
AQ
09/28Seegene, Inc.'s Equity Buyback announced on March 9, 2021, has expired.
CI
09/27SEEGENE : Unveils Fully Automated Molecular Testing System at the 2021 AACC
AQ
More news
Financials
Sales 2021 1 256 B 1,06 B 1,06 B
Net income 2021 465 B 0,39 B 0,39 B
Net cash 2021 550 B 0,47 B 0,47 B
P/E ratio 2021 7,48x
Yield 2021 1,47%
Capitalization 3 341 B 2 823 M 2 826 M
EV / Sales 2021 2,22x
EV / Sales 2022 3,12x
Nbr of Employees 985
Free-Float 67,6%
Chart SEEGENE, INC.
Duration : Period :
Seegene, Inc. Technical Analysis Chart | A096530 | KR7096530001 | MarketScreener
Technical analysis trends SEEGENE, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 66 500,00 KRW
Average target price 79 000,00 KRW
Spread / Average Target 18,8%
EPS Revisions
Managers and Directors
Jong-Yoon Chun Chief Executive Officer & Director
Jung-Yong Kim Director & Head-Finance
Hong-Il Yoon Independent Director
Chang-Se Lee Independent Director
Kyung-Jun Chun Director
Sector and Competitors
1st jan.Capi. (M$)
SEEGENE, INC.-31.09%2 910
EXACT SCIENCES CORPORATION-39.19%13 198
GUARDANT HEALTH, INC.-24.22%9 220
BGI GENOMICS CO., LTD.-28.68%5 894
ADAPTIVE BIOTECHNOLOGIES CORPORATION-55.64%3 579
INVITAE CORPORATION-64.15%3 393